Price (delayed)
$195.845
Market cap
$5.84B
P/E Ratio
932.6
Dividend/share
N/A
EPS
$0.21
Enterprise value
$5.68B
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the
There are no recent dividends present for INSP.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.